-
Eagle Pharma Has 'Several Upcoming Catalysts' And Is A Buy, RBC Says
Monday, June 22, 2015 - 3:58pm | 357Read More...Shares of Eagle Pharmaceuticals Inc (NASDAQ: EGRX) continue to rise on Monday, as they have been doing since the beginning of the year. Earlier this morning, RBC Capital Markets analysts Randall Stanicky and James C Chen initiated coverage on the stock with an Outperform rating and a $97.00 price...
-
Mizuho Analyst On The Fence At Medicines Co. Pending Patent Appeal
Saturday, April 11, 2015 - 12:49pm | 272Read More...Uncertainty over patents on The Medicines Company (NASDAQ: MDCO)'s lead blood-clot drug Angiomax will hurt results going forward, an analyst said Friday. Hospira, Inc. (NYSE: HSP) is set to launch a generic version of Angiomax in June under a court ruling concerning a patent dispute last...
-
Market Wrap For April 1: S&P 500 Hitting New All-Time High Not An April Fools' Joke
Tuesday, April 1, 2014 - 4:47pm | 1704Read More...U.S. stocks kicked off a new month and new quarter with solid gains as U.S. manufacturing growth improved in March. The indexes have now logged a three-day winning streak, an accomplishment which was completely absent throughout all of March. The S&P 500 hit new all-time highs of 1,885.84...
